DISCOVER NOW
Yokota Japan Clinical Studies
Clinical studies, or clinical trials, are research investigations involving human participants to assess the safety and effectiveness of new medical treatments, drugs, or procedures. This follow strict protocols to gather...
Yokota Japan Clinical Studies
Clinical studies, or clinical trials, are research investigations involving human participants to assess the safety and effectiveness of new medical treatments, drugs, or procedures. This follow strict protocols to gather...
What is NcPA®
NcPA®: Natural form of cyclic lysophosphatidic acid (cPA). Kimiko Murobushi, Professor Emeritus at Ochanomizu University, discovered in 1985 an “unknown bioactive substance” from a fungal slime mold. Phospholipids with a...
What is NcPA®
NcPA®: Natural form of cyclic lysophosphatidic acid (cPA). Kimiko Murobushi, Professor Emeritus at Ochanomizu University, discovered in 1985 an “unknown bioactive substance” from a fungal slime mold. Phospholipids with a...
Active Ingredients and The Latest Technology
Our Active Ingridients Sodium Cyclic Lysophosphatidic Acid (NcPA®) Bakuchiol Dipeptide Diaminobutyroyl Benzylamide Diacetate Palmitoyl Pentapeptide-4 Malus Domestica Fruit Cell Culture Extract Hydrolyzed Hyaluronic acid Hydrolyzed Collagen Niacinamide Our Latest Technology...
Active Ingredients and The Latest Technology
Our Active Ingridients Sodium Cyclic Lysophosphatidic Acid (NcPA®) Bakuchiol Dipeptide Diaminobutyroyl Benzylamide Diacetate Palmitoyl Pentapeptide-4 Malus Domestica Fruit Cell Culture Extract Hydrolyzed Hyaluronic acid Hydrolyzed Collagen Niacinamide Our Latest Technology...
NcPA® Characteristics as a Cosmetic Raw Material
Good solubility in water (~50mg/mL) because it is a sodium salt. INCI registered (INCI No. 26502, Sodium Cyclic Lysophosphatidic Acid). Quasi-drugs approved (additive, approved on January 20, 2020). About 50~70%...
NcPA® Characteristics as a Cosmetic Raw Material
Good solubility in water (~50mg/mL) because it is a sodium salt. INCI registered (INCI No. 26502, Sodium Cyclic Lysophosphatidic Acid). Quasi-drugs approved (additive, approved on January 20, 2020). About 50~70%...
Manufacturing Process of NcPA
SANSHO’ s unique technology has established a mass production process. Patent No. 5933338 Production method and composition of cyclic sodium phosphatidic acid Patent Application 2017-237364: Production method of cyclic sodium...
Manufacturing Process of NcPA
SANSHO’ s unique technology has established a mass production process. Patent No. 5933338 Production method and composition of cyclic sodium phosphatidic acid Patent Application 2017-237364: Production method of cyclic sodium...
Smart Capsule
The product adopts the patented microcapsule of the latest technology, which can sense the damaged parts of the skin and selectively release beauty ingredients. The essence is to concentrate on...
Smart Capsule
The product adopts the patented microcapsule of the latest technology, which can sense the damaged parts of the skin and selectively release beauty ingredients. The essence is to concentrate on...